Subscribe To Our Free Newsletter |
Auro Pharma rises on USFDA nod for nasal spray
Aurobindo Pharma added 1.28% to Rs 1,002.05 after the drug maker received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Mometasone Furoate Monohydrate Nasal Spray.